141 related articles for article (PubMed ID: 6946242)
1. Frequency of an allele for low activity of alpha-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients.
Barlow JJ; DiCioccio RA; Dillard PH; Blumenson LE; Matta KL
J Natl Cancer Inst; 1981 Nov; 67(5):1005-9. PubMed ID: 6946242
[TBL] [Abstract][Full Text] [Related]
2. Serum alpha-fucosidase and hexosaminidase as biological markers in human cancer.
De Martínez NR; Castro N
Medicina (B Aires); 1982; 42(1):36-42. PubMed ID: 7132700
[No Abstract] [Full Text] [Related]
3. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. Plasma alpha-L-fucosidase activity and the risk of borderline epithelial ovarian tumors.
Harlow BL; Weiss NS; Holmes EH
Cancer Res; 1990 Aug; 50(15):4702-3. PubMed ID: 2164446
[TBL] [Abstract][Full Text] [Related]
6. Fucosyltransferase and alpha-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue.
Wang JW; Ambros RA; Weber PB; Rosano TG
Cancer Res; 1995 Aug; 55(16):3654-8. PubMed ID: 7627975
[TBL] [Abstract][Full Text] [Related]
7. Plasma alpha-L-fucosidase: presence of a low activity variant in some normal individuals.
Wood S
J Lab Clin Med; 1976 Sep; 88(3):469-76. PubMed ID: 956698
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
[TBL] [Abstract][Full Text] [Related]
9. Serum alpha-mannosidase in patients with alcoholic liver disease.
Faber CN; Glew RH; Stanko RT
Enzyme; 1984; 31(1):1-10. PubMed ID: 6714194
[TBL] [Abstract][Full Text] [Related]
10. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
11. Tumour-associated antigens for cystadenocarcinoma of the ovary.
Barlow JJ; Bhattacharya M
Clin Obstet Gynaecol; 1983 Aug; 10(2):187-96. PubMed ID: 6413113
[TBL] [Abstract][Full Text] [Related]
12. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; Dite GS; McCredie MR; Giles GG; Venter DJ; Southey MC; Purdie DM; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
[TBL] [Abstract][Full Text] [Related]
13. Characterization of alpha-L-fucosidase from two different families with fucosidosis.
Troost J; van der Heijden MC; Staal GE
Clin Chim Acta; 1976 Dec; 73(2):329-46. PubMed ID: 11911
[TBL] [Abstract][Full Text] [Related]
14. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
15. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
16. Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
Bhattacharya M; Chatterjee SK; Barlow JJ
Cancer Res; 1976 Jun; 36(6):2096-101. PubMed ID: 57828
[TBL] [Abstract][Full Text] [Related]
17. Alpha-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence.
Fernández-Rodríguez J; Ayude D; de la Cadena MP; Martínez-Zorzano VS; de Carlos A; Caride-Castro A; de Castro G; Rodríguez-Berrocal FJ
Cancer Detect Prev; 2000; 24(2):143-9. PubMed ID: 10917134
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
19. Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.
Abdel-Aleem H; Ahmed A; Sabra AM; Zakhari M; Soliman M; Hamed H
Int J Gynaecol Obstet; 1996 Dec; 55(3):273-9. PubMed ID: 9003953
[TBL] [Abstract][Full Text] [Related]
20. alpha-L-fucosidase variant and lipid-associated sialic acid in hereditary ovarian cancer.
Wells IC; Lynch HT; Lynch JF
Cancer Genet Cytogenet; 1987 Apr; 25(2):247-51. PubMed ID: 3470114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
